Christina Guiton, MD, joins the PharmAdvice PV Team
I am happy to announce that Christina Guiton has joined the PharmAdvice pharmacovigilance team as QPPV and pharmacovigilance manager.
Christina Guiton is a medical doctor with more than 20 years of experience within the pharma industry.
Extension of pilot period for MAH requirements
On 22 November 2017, EMA launched the new EudraVigilance system. All marketing authorisation holders (MAHs) were required to monitor EudraVigilance data with a start date of 22 February 2018.
In August 2022 EMA and the European Commission agreed to further extend the pilot until the end of 2023.